Journal of PsychopharmacologyNeurosciencePeer-reviewed journal article
How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans.
Abstract
Psilocybin is the active component of magic mushrooms and is well known for its psychoactive properties. Different questionnaires have been developed to systematically quantify altered states of consciousness induced by psychoactive drugs. The aim of this study was to obtain the dose-response relationships of the subjective experiences induced by psilocybin in healthy study participants. For this purpose, we applied a linear meta-regression approach on questionnaire ratings after oral administration of psilocybin in a controlled setting. Data was obtained from The Altered States Database, which contains psychometric data extracted from peer-reviewed articles published in MEDLINE-listed journals that used standardized and validated questionnaires. Our meta-analysis included data of the Altered States of Consciousness Rating Scale, the Mystical Experience Questionnaire (MEQ30), and the Hallucinogen Rating Scale (HRS). We used the Robust Variance Estimation Framework to obtain linear dose-response relationship estimates for each dimension of the given questionnaires. Ratings on most dimensions and subscales of the included questionnaires correlated positively with dose. Since subjective experiences are not only determined by dose, but also by individual differences and environmental factors, our results do not necessarily generalize to recreational use, as our analyses are based on data from controlled laboratory experiments. The paper at hand could serve as a general literature citation for the use of psilocybin in experimental and clinical research, especially for the comparison of expected and observed subjective drug experiences.
- Citations
- 93
- FWCI
- 9.88
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dose-response relationships of LSD-induced subjective experiences in humans
Tim Hirschfeld, Johanna Prugger, … Timo Torsten Schmidt·NeuropsychopharmacologyPeer-reviewed·May 9, 2023
- Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity
Federico Cavanna, Stephanie L. Muller, … Enzo Tagliazucchi·bioRxiv·Nov 30, 2021
- Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review
R. J. Shore, K. Dobson, … E. Dumont·bioRxiv·Jan 4, 2024
- Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.
Evan Fuini, Arnold Chang, … Craig F. Ferris·Frontiers in NeurosciencePeer-reviewed·May 1, 2025
- Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience
Christopher R. N. Nicholas, Matthew I. Banks, … Charles L. Raison·Translational PsychiatryPeer-reviewed·Sep 12, 2024
- Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology
Kenneth Shinozuka, Katarina Jerotic, … Morten L. Kringelbach·Translational PsychiatryPeer-reviewed·Dec 4, 2024